Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxelFLEMING, Gini F; WAGGONER, Steven E; ROTMENSCH, Jacob et al.American journal of clinical oncology. 2001, Vol 24, Num 1, pp 52-57, issn 0277-3732Article

Systemic chemotherapy for uterine carcinoma : Metastatic and adjuvantFLEMING, Gini F.Journal of clinical oncology. 2007, Vol 25, Num 20, pp 2983-2990, issn 0732-183X, 8 p.Article

Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer : a gynaecological oncology group studyMOULD, Diane R; FLEMING, Gini F; DARCY, Kathleen M et al.British journal of clinical pharmacology. 2006, Vol 62, Num 1, pp 56-70, issn 0306-5251, 15 p.Article

State anxiety and cancer-specific anxiety in survivors of breast cancerROTHROCK, Nan E; MATTHEWS, Alicia K; SELLERGREN, Sarah A et al.Journal of psychosocial oncology. 2004, Vol 22, Num 4, pp 93-109, issn 0734-7332, 17 p.Article

Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairmentLATHIA, Chetan; FLEMING, Gini F; MEYER, Mark et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 2, pp 121-126, issn 0344-5704Article

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignanciesMUNDT, Arno J; LUJAN, Anthony E; ROTMENSCH, Jacob et al.International journal of radiation oncology, biology, physics. 2002, Vol 52, Num 5, pp 1330-1337, issn 0360-3016Conference Paper

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer : A Trial of the California, Chicago, and Princess Margaret Hospital Phase II ConsortiaGARCIA, Agustin A; HIRTE, Hal; SCUDDER, Sidney et al.Journal of clinical oncology. 2008, Vol 26, Num 1, pp 76-82, issn 0732-183X, 7 p.Article

ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancerMATULONIS, Ursula A; LEE, Julie; ARNOTT, Jamie et al.European journal of cancer (1990). 2013, Vol 49, Num 1, pp 121-131, issn 0959-8049, 11 p.Article

Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancerHENDERSON, I. Craig; BERRY, Donald A; FLEMING, Gini et al.Journal of clinical oncology. 2003, Vol 21, Num 6, pp 976-983, issn 0732-183X, 8 p.Article

Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignanciesMUNDT, Arno J; ROTMENSCH, Jacob; WAGGONER, Steven E et al.Gynecologic oncology (Print). 2001, Vol 82, Num 2, pp 333-337, issn 0090-8258Article

A phase I trial of pharmacokinetic modulation of carboxyamidotriazole (CAI) with ketoconazole in patients with advanced cancerDESAI, Apurva A; INNOCENTI, Federico; JANISCH, Linda et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 5, pp 377-384, issn 0344-5704, 8 p.Article

Chemotherapy Intensity and Toxicity Among Black and White Women With Advanced and Recurrent Endometrial Cancer: A Gynecologic Oncology Group StudyFARLEY, John H; CHUNQIAO TIAN; ROSE, G. Scott et al.Cancer. 2010, Vol 116, Num 2, pp 355-361, issn 0008-543X, 7 p.Article

A phase i trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: Report of cancer and leukemia group B 9661FLEMING, Gini F; MEROPOL, Neal J; RATAIN, Mark J et al.Clinical cancer research. 2002, Vol 8, Num 12, pp 3718-3727, issn 1078-0432, 10 p.Article

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies : A Gynecologic Oncology Group StudyFLEMING, Gini F; FOWLER, Jeffrey M; MCGUIRE, William P et al.Journal of clinical oncology. 2001, Vol 19, Num 4, pp 1021-1029, issn 0732-183XArticle

Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expressionPOELMAN, Susan M; ADEYANJU, Moses O; ROBERTSON, Maria-Antonia et al.Clinical cancer research. 2000, Vol 6, Num 10, pp 4043-4048, issn 1078-0432Article

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancerMA, Cynthia X; SUMAN, Vera J; ERLICHMAN, Charles et al.Breast cancer research and treatment. 2013, Vol 139, Num 1, pp 145-153, issn 0167-6806, 9 p.Article

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumabMANI, Aruna; RODA, Julie; YOUNG, Donn et al.Breast cancer research and treatment. 2009, Vol 117, Num 1, pp 83-89, issn 0167-6806, 7 p.Article

Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancerWEI PENG YONG; DESAI, Apurva A; RATAIN, Mark J et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 6, pp 811-819, issn 0344-5704, 9 p.Article

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A gynecologic oncology group studyFLEMING, Gini F; BRUNETTO, Virginia L; CELLA, David et al.Journal of clinical oncology. 2004, Vol 22, Num 11, pp 2159-2166, issn 0732-183X, 8 p.Article

Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma : A gynecologic oncology group studyMAXWELL, G. Larry; CHUNQIAO TIAN; RISINGER, John et al.Cancer. 2006, Vol 107, Num 9, pp 2197-2205, issn 0008-543X, 9 p.Article

Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer PatientsCOHEN, Ezra E. W; KEHUA WU; HOUSE, Larry et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4785-4793, issn 1078-0432, 9 p.Article

Phase II trial of temsirolimus in patients with metastatic breast cancerFLEMING, Gini F; MA, Cynthia X; NAUGHTON, M. J et al.Breast cancer research and treatment. 2012, Vol 136, Num 2, pp 355-363, issn 0167-6806, 9 p.Article

Incorporation of Bevacizumab in the Primary Treatment of Ovarian CancerBURGER, Robert A; BRADY, Mark F; BOENTE, Matthew et al.The New England journal of medicine. 2011, Vol 365, Num 26, pp 2473-2483, issn 0028-4793, 11 p.Article

Racial Differences in Clinical Outcomes From Metastatic Breast Cancer : A Pooled Analysis of CALGB 9342 and 9840-Cancer and Leukemia Group BPOLITE, Blase N; CIRRINCIONE, Constance; LAKE, Diana et al.Journal of clinical oncology. 2008, Vol 26, Num 16, pp 2659-2665, issn 0732-183X, 7 p.Article

Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial. DiscussionOLSON, John A; BUDD, G. Thomas; BAE, Kyongtae et al.Journal of the American College of Surgeons. 2009, Vol 208, Num 5, pp 906-916, issn 1072-7515, 11 p.Conference Paper